Psychiatry and Neurology, Neurology · San Diego, CA
NPI
1225474034
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
4510 Executive Dr Ste 325
San Diego, CA, 92121
Phone (858) 543-8540
Groups this clinician bills Medicare through
Medicare paid, 2024
$526K
313,994 services
Medicare patients, 2024
543
Average age 74
Drug cost, 2024
$1.6M
5,747 prescriptions
Company payments, 2025
$69K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Soria-Lopez was code J0174 (injection, lecanemab-irmb, 1 mg), 310,708 times for 36 patients. In total Jose A Soria-Lopez billed 313,994 services in 34 codes, and Medicare paid $526K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 310,708 | 36 | $1.05 | $325K |
| 96127 Behavioral Health Services | Office | 554 | 267 | $3.58 | $1,986 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 540 | 321 | $12.49 | $6,742 |
| 99215 Office E&M - Established | Office | 458 | 268 | $135.91 | $62K |
| 96413 Chemotherapy Administration | Office | 390 | 38 | $114.90 | $45K |
| 99214 Office E&M - Established | Office | 200 | 169 | $95.06 | $19K |
| 99205 Office E&M - New | Office | 116 | 116 | $146.46 | $17K |
| 99204 Office E&M - New | Office | 96 | 96 | $104.41 | $10K |
| 62270 Musculoskeletal | Office | 19 | 19 | $110.73 | $2,104 |
| 99483 Office/Outpatient Services | Office | 16 | 16 | $202.77 | $3,244 |
| 99213 Office E&M - Established | Office | 16 | 15 | $74.01 | $1,184 |
| 76942 Ultrasound - Nonspecific | Office | 14 | 14 | $43.19 | $605 |
By year: 2022 $156K for 5,633 services; 2023 $123K for 23,656 services; 2024 $526K for 313,994 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Soria-Lopez prescribed most often to Medicare patients was Donepezil Hcl, with 1,400 prescriptions and refills. In total Jose A Soria-Lopez wrote 5,747 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 1,400 | 3,014 | 451 | $32K |
| Memantine Hcl Generic | 522 | 977 | 161 | $25K |
| Gabapentin Generic | 453 | 725 | 125 | $5,831 |
| Sertraline Hcl Generic | 430 | 1,064 | 143 | $4,779 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 369 | 691 | 95 | $12K |
| Trazodone Hcl Generic | 273 | 661 | 104 | $2,467 |
| Rytary Carbidopa/Levodopa | 139 | 181 | 28 | $95K |
| Levetiracetam Generic | 138 | 274 | 42 | $2,651 |
| Quetiapine Fumarate Generic | 106 | 209 | 40 | $2,923 |
| Rivastigmine Generic | 104 | 163 | 31 | $18K |
| Clonazepam Generic | 88 | 152 | 32 | $1,904 |
| Escitalopram Oxalate Generic | 75 | 158 | 25 | $1,054 |
| Baclofen Generic | 62 | 101 | 23 | $1,590 |
| Primidone Generic | 62 | 134 | 17 | $1,444 |
| Mirtazapine Generic | 58 | 167 | 22 | $1,336 |
Brand drugs: 542 claims; generic drugs: 5,205 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Soria-Lopez $69K ($66K in general payments such as food, travel and fees and $3,355 for research) from 19 companies. The largest payer was Lilly USA, LLC with $42K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 55 | $42K |
| Eisai Inc. 4523.T | 27 | $19K |
| Eli Lilly and Company LLY | 1 | $3,355 |
| Biogen, Inc. BIIB | 3 | $3,046 |
| Abbvie Inc. ABBV | 33 | $596 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $144 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $107 |
| UCB, Inc. UCB.BR | 2 | $85.84 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $57.35 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $49.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.